- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Electroacupuncture relieves Opioid-induced constipation in cancer patients: JAMA
China: An original investigation of Complementary and Alternative Medicine published in JAMA Network Open concluded that an 8-week Electroacupuncture (EA) treatment has stable benefits and a good safety profile for Opioid-induced constipation (OIC) in adult patients with cancer.
The researchers have clarified that EA has no interference with opioid analgesia and is a good alternative for managing such patients suffering from chronic cancer pain.
Cancer patients treated with opioids have a high prevalence of OIC. There exists an unmet need for the availability of safe and effective therapies for such conditions.
The question here is,
“ Is EA efficacious and safe for managing OIC in adult cancer patients?”
Considering this background, researchers conducted randomised clinical trials at six tertiary hospitals in China. The researchers included 100 patients with cancer and opioid-induced constipation.
The study points are:
- There were 56 men and 44 women in the study, with a mean age of 64.4 years.
- There were two groups, EA (Electroacupuncture) and SA (Sham electroacupuncture).
- EA group received 30 min EA sessions at six acupoints thrice weekly for eight weeks.
- The SA group received 30 min SA sessions at six non-acupoints thrice weekly for eight weeks.
- The primary outcome measured was the proportion of overall responders, ≥ three spontaneous bowel movements (SBM) per week and an increase of ≥ 1 SBM from baseline.
- The intervention period was eight weeks.
- The proportion of overall responders at week 8 was 40.1% and 9 % in the EA and SA groups, respectively.
- The adverse events are rare, and if they occur, they are mild and transient.
The researchers finally said that EA provides more significant relief for most OIC symptoms and hence improves the life quality of such patients.
8-week EA treatment increases weekly bowel movements and is a good alternative.
Further reading:
Wang W, Liu Y, Yang X, et al. Effects of Electroacupuncture for Opioid-Induced Constipation in Patients With Cancer in China: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e230310. doi:10.1001/jamanetworkopen.2023.0310
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751